We selected four hub genes, LAPTM5, C1QC, CSF1R, and SLCO2B1, and analyzed their correlation with the tumor infiltration of 22 immune cell subsets using CIBERSORT [16] and the prognosis of different immunity-related LUSC patient subtypes. This evidence concerns the gene LAPTM5 and neoplasm.